Page last updated: 2024-08-23

phosphotyrosine and Bile Duct Cancer

phosphotyrosine has been researched along with Bile Duct Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aigelsreiter, A; Birkl-Toeglhofer, AM; Fickert, P; Garbers, C; Golob-Schwarzl, N; Haybaeck, J; Hofer, E; Kleinegger, F; Krassnig, S; Lax, S; Mangge, H; Moriggl, R; Niedrist, T; Orlova, A; Park, YN; Petzold, J; Reihs, R; Rinner, B; Rose-John, S; Stallinger, A; Thalhammer, M; Wodlej, C	1

Other Studies

1 other study(ies) available for phosphotyrosine and Bile Duct Cancer

Article	Year
Pharmacologic IL-6Rα inhibition in cholangiocarcinoma promotes cancer cell growth and survival. Biochimica et biophysica acta. Molecular basis of disease, 2019, 02-01, Volume: 1865, Issue:2 Topics: Aged; Antibodies, Monoclonal, Humanized; Apoptosis; Bile Duct Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cholangiocarcinoma; Down-Regulation; Female; G2 Phase; Gallbladder; Humans; Interleukin-6; Male; Middle Aged; Mitosis; Models, Biological; Phosphorylation; Phosphotyrosine; Receptors, Interleukin-6; Recombinant Fusion Proteins; Signal Transduction; STAT3 Transcription Factor; Survival Analysis	2019

Article

Year

Pharmacologic IL-6Rα inhibition in cholangiocarcinoma promotes cancer cell growth and survival.

Biochimica et biophysica acta. Molecular basis of disease, 2019, 02-01, Volume: 1865, Issue:2

Topics: Aged; Antibodies, Monoclonal, Humanized; Apoptosis; Bile Duct Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cholangiocarcinoma; Down-Regulation; Female; G2 Phase; Gallbladder; Humans; Interleukin-6; Male; Middle Aged; Mitosis; Models, Biological; Phosphorylation; Phosphotyrosine; Receptors, Interleukin-6; Recombinant Fusion Proteins; Signal Transduction; STAT3 Transcription Factor; Survival Analysis

2019